Number of the records: 1  

When and how important is anti-fibrotic therapy in the post-COVID-19 period?

  1. TitleWhen and how important is anti-fibrotic therapy in the post-COVID-19 period?
    Author infoKerget Bugra ... [et al.]
    Co-authors Kerget Bugra
    NoteBibliogr. odkazy. - Res. angl.
    Sign.C 526
    Source Bratislavské lekárske listy : international journal for biomedical sciences and clinical medicine. - ISSN 0006-9248. - Bratislava : AEPress , 2022 . - Vol. 123, no. 9 (2022), s. 653-658  : ilustr., obr., tab.
    MeSH Subject COVID-19 : komplikácie
    látky antifibrotické : použitie terapeutické
    pyridóny
    vyšetrenia respiračné funkčné
    výsledok liečby
    Subj. Headings syndróm post-COVID-19 (long COVID-19) * pirfenidón * vyhodnotenie súboru pacientov
    LanguageEnglish
    CountrySlovak Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.